# AUGMENTIN™ in Dental Infections

> **NCT02141217** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 472 (actual)

## Conditions studied

- Focal Infection, Dental

## Interventions

- **DRUG:** Amoxicillin/clavulanate
- **DRUG:** Clindamycin

## Key facts

- **NCT ID:** NCT02141217
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-21
- **Primary completion:** 2013-12-28
- **Final completion:** 2013-12-28
- **Target enrollment:** 472 (ACTUAL)
- **Last updated:** 2017-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02141217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02141217, "AUGMENTIN™ in Dental Infections". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02141217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*